| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.33e-04 | 16 | 34 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.79e-04 | 21 | 34 | 2 | GO:0030228 | |
| GeneOntologyCellularComponent | extracellular matrix | 7.26e-07 | 656 | 34 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 7.44e-07 | 658 | 34 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.90e-04 | 530 | 34 | 6 | GO:0062023 | |
| HumanPheno | Abnormality of the chin | 4.11e-05 | 409 | 10 | 6 | HP:0000306 | |
| Domain | Growth_fac_rcpt_ | 2.83e-07 | 156 | 33 | 6 | IPR009030 | |
| Domain | DUF5050 | 3.03e-06 | 2 | 33 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.03e-06 | 2 | 33 | 2 | PF16472 | |
| Domain | EGF_3 | 3.10e-06 | 235 | 33 | 6 | PS50026 | |
| Domain | EGF | 3.10e-06 | 235 | 33 | 6 | SM00181 | |
| Domain | EGF_extracell | 3.67e-06 | 60 | 33 | 4 | IPR013111 | |
| Domain | EGF_2 | 3.67e-06 | 60 | 33 | 4 | PF07974 | |
| Domain | EGF-like_dom | 4.33e-06 | 249 | 33 | 6 | IPR000742 | |
| Domain | TSP_1 | 4.47e-06 | 63 | 33 | 4 | PF00090 | |
| Domain | EGF_1 | 4.97e-06 | 255 | 33 | 6 | PS00022 | |
| Domain | TSP1 | 5.07e-06 | 65 | 33 | 4 | SM00209 | |
| Domain | TSP1_rpt | 5.07e-06 | 65 | 33 | 4 | IPR000884 | |
| Domain | TSP1 | 5.07e-06 | 65 | 33 | 4 | PS50092 | |
| Domain | EGF-like_CS | 5.67e-06 | 261 | 33 | 6 | IPR013032 | |
| Domain | EGF_2 | 6.19e-06 | 265 | 33 | 6 | PS01186 | |
| Domain | EGF | 6.94e-05 | 126 | 33 | 4 | PF00008 | |
| Domain | LRRNT | 1.11e-04 | 53 | 33 | 3 | PF01462 | |
| Domain | Ldl_recept_b | 2.72e-04 | 14 | 33 | 2 | PF00058 | |
| Domain | LDLRB | 2.72e-04 | 14 | 33 | 2 | PS51120 | |
| Domain | PLAC | 2.72e-04 | 14 | 33 | 2 | PF08686 | |
| Domain | LY | 3.13e-04 | 15 | 33 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.13e-04 | 15 | 33 | 2 | IPR000033 | |
| Domain | EGF_CA | 4.65e-04 | 86 | 33 | 3 | PF07645 | |
| Domain | PLAC | 5.08e-04 | 19 | 33 | 2 | IPR010909 | |
| Domain | PLAC | 5.08e-04 | 19 | 33 | 2 | PS50900 | |
| Domain | EGF_Ca-bd_CS | 6.62e-04 | 97 | 33 | 3 | IPR018097 | |
| Domain | LRRNT | 6.82e-04 | 98 | 33 | 3 | IPR000372 | |
| Domain | LRRNT | 6.82e-04 | 98 | 33 | 3 | SM00013 | |
| Domain | EGF_CA | 7.02e-04 | 99 | 33 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.23e-04 | 100 | 33 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.57e-04 | 106 | 33 | 3 | IPR000152 | |
| Domain | Ephrin_rec_like | 8.85e-04 | 25 | 33 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 8.85e-04 | 25 | 33 | 2 | IPR011641 | |
| Domain | cEGF | 9.58e-04 | 26 | 33 | 2 | IPR026823 | |
| Domain | cEGF | 9.58e-04 | 26 | 33 | 2 | PF12662 | |
| Domain | EGF_LAM_2 | 1.28e-03 | 30 | 33 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.28e-03 | 30 | 33 | 2 | PS01248 | |
| Domain | EGF_CA | 1.29e-03 | 122 | 33 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.35e-03 | 124 | 33 | 3 | IPR001881 | |
| Domain | Plexin_repeat | 1.45e-03 | 32 | 33 | 2 | IPR002165 | |
| Domain | PSI | 1.45e-03 | 32 | 33 | 2 | PF01437 | |
| Domain | EGF_Lam | 1.74e-03 | 35 | 33 | 2 | SM00180 | |
| Domain | Laminin_EGF | 2.05e-03 | 38 | 33 | 2 | IPR002049 | |
| Domain | - | 2.15e-03 | 39 | 33 | 2 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 2.26e-03 | 40 | 33 | 2 | IPR023415 | |
| Domain | PSI | 2.73e-03 | 44 | 33 | 2 | IPR016201 | |
| Domain | Ldl_recept_a | 2.86e-03 | 45 | 33 | 2 | PF00057 | |
| Domain | PSI | 2.98e-03 | 46 | 33 | 2 | SM00423 | |
| Domain | - | 2.98e-03 | 46 | 33 | 2 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.98e-03 | 46 | 33 | 2 | IPR011042 | |
| Domain | - | 3.25e-03 | 48 | 33 | 2 | 2.120.10.80 | |
| Domain | LDLRA_1 | 3.25e-03 | 48 | 33 | 2 | PS01209 | |
| Domain | LRR_8 | 3.36e-03 | 171 | 33 | 3 | PF13855 | |
| Domain | LDrepeatLR_classA_rpt | 3.38e-03 | 49 | 33 | 2 | IPR002172 | |
| Domain | LDLa | 3.38e-03 | 49 | 33 | 2 | SM00192 | |
| Domain | CUB | 3.38e-03 | 49 | 33 | 2 | PF00431 | |
| Domain | LDLRA_2 | 3.38e-03 | 49 | 33 | 2 | PS50068 | |
| Domain | CUB | 3.52e-03 | 50 | 33 | 2 | SM00042 | |
| Domain | Leu-rich_rpt_typical-subtyp | 3.70e-03 | 177 | 33 | 3 | IPR003591 | |
| Domain | LRR_TYP | 3.70e-03 | 177 | 33 | 3 | SM00369 | |
| Domain | - | 3.80e-03 | 52 | 33 | 2 | 2.60.120.290 | |
| Domain | CUB | 3.94e-03 | 53 | 33 | 2 | PS01180 | |
| Domain | Kelch-typ_b-propeller | 4.24e-03 | 55 | 33 | 2 | IPR015915 | |
| Domain | CUB_dom | 4.55e-03 | 57 | 33 | 2 | IPR000859 | |
| Domain | LRR | 5.28e-03 | 201 | 33 | 3 | PS51450 | |
| Domain | LRR_1 | 6.70e-03 | 219 | 33 | 3 | PF00560 | |
| Domain | Kelch_1 | 6.78e-03 | 70 | 33 | 2 | PF01344 | |
| Domain | Kelch_1 | 6.78e-03 | 70 | 33 | 2 | IPR006652 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.09e-06 | 68 | 23 | 4 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.34e-05 | 39 | 23 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.34e-05 | 39 | 23 | 3 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 7.74e-05 | 143 | 23 | 4 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 6.56e-04 | 250 | 23 | 4 | M27554 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.12e-04 | 109 | 23 | 3 | MM15164 | |
| Pathway | WP_THYROXINE_THYROID_HORMONE_PRODUCTION | 7.47e-04 | 25 | 23 | 2 | M39353 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.50e-04 | 111 | 23 | 3 | M27416 | |
| Pathway | PID_REELIN_PATHWAY | 9.38e-04 | 28 | 23 | 2 | M69 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 1.30e-03 | 33 | 23 | 2 | MM1426 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 1.38e-03 | 34 | 23 | 2 | M3342 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 2.01e-03 | 41 | 23 | 2 | M159 | |
| Pubmed | 8.81e-07 | 75 | 34 | 4 | 20637190 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 9.28e-07 | 2 | 34 | 2 | 15963947 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18064672 | ||
| Pubmed | Reelin, Rap1 and N-cadherin orient the migration of multipolar neurons in the developing neocortex. | 2.78e-06 | 3 | 34 | 2 | 21516100 | |
| Pubmed | 4.95e-06 | 257 | 34 | 5 | 16335952 | ||
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 38462037 | ||
| Pubmed | Genetic and phenotypic studies of the dark-like mutant mouse. | 9.26e-06 | 5 | 34 | 2 | 18821597 | |
| Pubmed | Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. | 1.39e-05 | 6 | 34 | 2 | 18957219 | |
| Pubmed | 2.59e-05 | 8 | 34 | 2 | 10380922 | ||
| Pubmed | CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function. | 2.59e-05 | 8 | 34 | 2 | 20215401 | |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 4.15e-05 | 10 | 34 | 2 | 20368620 | |
| Pubmed | 5.07e-05 | 11 | 34 | 2 | 23612905 | ||
| Pubmed | 5.07e-05 | 11 | 34 | 2 | 24639464 | ||
| Pubmed | 5.07e-05 | 11 | 34 | 2 | 28165338 | ||
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 6.08e-05 | 12 | 34 | 2 | 8618961 | |
| Pubmed | 6.08e-05 | 12 | 34 | 2 | 10952903 | ||
| Pubmed | 7.19e-05 | 13 | 34 | 2 | 22724066 | ||
| Pubmed | 8.38e-05 | 14 | 34 | 2 | 15082773 | ||
| Pubmed | 1.25e-04 | 17 | 34 | 2 | 21315259 | ||
| Pubmed | SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development. | 1.25e-04 | 17 | 34 | 2 | 27234298 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.33e-04 | 101 | 34 | 3 | 23382219 | |
| Pubmed | 1.49e-04 | 105 | 34 | 3 | 9628581 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.93e-04 | 21 | 34 | 2 | 21337463 | |
| Pubmed | 2.07e-04 | 1285 | 34 | 7 | 35914814 | ||
| Pubmed | 2.74e-04 | 25 | 34 | 2 | 35815610 | ||
| Pubmed | 3.97e-04 | 30 | 34 | 2 | 19054571 | ||
| Pubmed | Conditional ablation of the Notch2 receptor in the ocular lens. | 4.24e-04 | 31 | 34 | 2 | 22173065 | |
| Pubmed | 5.83e-04 | 167 | 34 | 3 | 22159717 | ||
| Pubmed | 6.38e-04 | 38 | 34 | 2 | 29799838 | ||
| Pubmed | 6.68e-04 | 175 | 34 | 3 | 28071719 | ||
| Pubmed | Rbx2 regulates neuronal migration through different cullin 5-RING ligase adaptors. | 7.79e-04 | 42 | 34 | 2 | 24210661 | |
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 9.75e-04 | 47 | 34 | 2 | 14760718 | |
| Interaction | DEFB135 interactions | 4.40e-05 | 42 | 33 | 3 | int:DEFB135 | |
| Interaction | ZNF408 interactions | 8.94e-05 | 145 | 33 | 4 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 1.10e-04 | 57 | 33 | 3 | int:ZFP41 | |
| Interaction | ANKRD36B interactions | 1.28e-04 | 60 | 33 | 3 | int:ANKRD36B | |
| Interaction | PLAT interactions | 1.49e-04 | 63 | 33 | 3 | int:PLAT | |
| Interaction | NTF4 interactions | 1.70e-04 | 12 | 33 | 2 | int:NTF4 | |
| Interaction | RNASE4 interactions | 2.34e-04 | 14 | 33 | 2 | int:RNASE4 | |
| Interaction | DYRK1A interactions | 2.42e-04 | 552 | 33 | 6 | int:DYRK1A | |
| Interaction | IGFL3 interactions | 2.49e-04 | 75 | 33 | 3 | int:IGFL3 | |
| Cytoband | 1p13.3 | 1.21e-03 | 69 | 34 | 2 | 1p13.3 | |
| Cytoband | 3q29 | 1.74e-03 | 83 | 34 | 2 | 3q29 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q29 | 4.66e-03 | 137 | 34 | 2 | chr3q29 | |
| GeneFamily | ADAMTS like | 3.84e-05 | 7 | 25 | 2 | 947 | |
| GeneFamily | Low density lipoprotein receptors | 1.42e-04 | 13 | 25 | 2 | 634 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.46e-03 | 41 | 25 | 2 | 1298 | |
| Coexpression | NABA_MATRISOME | 2.74e-05 | 1008 | 33 | 8 | MM17056 | |
| Coexpression | NABA_MATRISOME | 3.11e-05 | 1026 | 33 | 8 | M5889 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.27e-08 | 148 | 34 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.95e-06 | 173 | 34 | 4 | 20f7dfe7d92a3dbec9da9a1f3185aa10cb8f0a3c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Neutrophil|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.58e-06 | 176 | 34 | 4 | 676839d07450b313222622e0ffd305c732cbad6d | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.00e-05 | 178 | 34 | 4 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.00e-05 | 178 | 34 | 4 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 182 | 34 | 4 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-05 | 184 | 34 | 4 | 9a185e6ea86bbfbb48bfe88650a8c05ceba78d7f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 184 | 34 | 4 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-05 | 187 | 34 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 1.27e-05 | 189 | 34 | 4 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 189 | 34 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 190 | 34 | 4 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 191 | 34 | 4 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 191 | 34 | 4 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.32e-05 | 191 | 34 | 4 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 191 | 34 | 4 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 192 | 34 | 4 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 192 | 34 | 4 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 192 | 34 | 4 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 192 | 34 | 4 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 193 | 34 | 4 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 194 | 34 | 4 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 194 | 34 | 4 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 194 | 34 | 4 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 194 | 34 | 4 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 194 | 34 | 4 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 195 | 34 | 4 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 195 | 34 | 4 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.43e-05 | 195 | 34 | 4 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.43e-05 | 195 | 34 | 4 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 195 | 34 | 4 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 196 | 34 | 4 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 196 | 34 | 4 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | Multiple_Sclerosis-Myeloid|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.52e-05 | 198 | 34 | 4 | 3c2817d95011ae372d0316ccf774e975536207b0 | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-CD14+_Monocyte|Leuk-UTI / Disease, condition lineage and cell class | 1.58e-05 | 200 | 34 | 4 | 04d0164b80d424a308ada3fea6bb4a9d6cf686e3 | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.58e-05 | 200 | 34 | 4 | 69e4727dda76aa13c4e95f10b9b217c3cd7478d8 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-05 | 200 | 34 | 4 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 130 | 34 | 3 | 7d4319aae42acc914757796877b8f0d874acbec4 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.48e-04 | 135 | 34 | 3 | 5b13ff740d9f7d96274aebb6b389a80f6004adc7 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-04 | 144 | 34 | 3 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 149 | 34 | 3 | 5a5e9660f7d9b527f50a92d94d4c0c8aedb82c0b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.98e-04 | 149 | 34 | 3 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 149 | 34 | 3 | 4de52569611e63a780cde9bd111d6d9c11a05a11 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.98e-04 | 149 | 34 | 3 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 149 | 34 | 3 | c957ac23ad6343eacce7e6be4a6d3ac043af4f86 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.01e-04 | 150 | 34 | 3 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-04 | 151 | 34 | 3 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 155 | 34 | 3 | c648512305166d2a2f0e284c127bc802af908071 | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.26e-04 | 156 | 34 | 3 | 166f7b1220eaf8e1149dde260dd85a094855c54f | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.26e-04 | 156 | 34 | 3 | 5e1c5a7c9293b886920739cf766521df7f69726c | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.44e-04 | 160 | 34 | 3 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 162 | 34 | 3 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 162 | 34 | 3 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 162 | 34 | 3 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-04 | 163 | 34 | 3 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-04 | 163 | 34 | 3 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.57e-04 | 163 | 34 | 3 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 165 | 34 | 3 | 9de841c1c95967c562720feba930246debc626fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 165 | 34 | 3 | a612a7d3a5415ecacc3df8fbff0ce498f982aad0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 165 | 34 | 3 | cdc94a640ec01c6892521bcd6f0ee0a66ff23866 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-04 | 166 | 34 | 3 | dd5944101ef58a9a29aa3eb5c17690119572b8f1 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-04 | 166 | 34 | 3 | 8e5e8de51b4dacdadaa5a08279df30b5c7ed3628 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.76e-04 | 167 | 34 | 3 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 168 | 34 | 3 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.81e-04 | 168 | 34 | 3 | 04259f5a9b067cd1b5619e34591e4b2fccc18535 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 168 | 34 | 3 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 168 | 34 | 3 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 169 | 34 | 3 | 3ad534303b4b60a77d171e605a1ba2ef20b5e2a3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 169 | 34 | 3 | 29dca061864c86218ab73a86cf6e3c522472da47 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-04 | 170 | 34 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.91e-04 | 170 | 34 | 3 | 403b6b749d70d845838dcda7daf99971b50792a2 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 2.91e-04 | 170 | 34 | 3 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.96e-04 | 171 | 34 | 3 | 87cb65648c663e246f94cea1a5ed12e8e29ec629 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 171 | 34 | 3 | fdd96c6fe850bd10e1e0d0f18c4401f8348b7d2c | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 171 | 34 | 3 | 6ab7f103cbdbd49ef687cbb8a42ddc5517af0f7f | |
| ToppCell | droplet-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 172 | 34 | 3 | f6c00a6a7e81aaf96c55eb3a3c88e3719f102ea0 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.01e-04 | 172 | 34 | 3 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-04 | 172 | 34 | 3 | f3bbe3f069ad070778430d1a6cd9db0a76deb8de | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 3.01e-04 | 172 | 34 | 3 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | 807183fc23478da9451906dacd88de4e73112e0d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | 2e683ec555dc0036875e0f5674dcc5e93ead205d | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.06e-04 | 173 | 34 | 3 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.11e-04 | 174 | 34 | 3 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.11e-04 | 174 | 34 | 3 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 175 | 34 | 3 | c8cfe0ac0c1ac447c626a623cc49692a0b177a1c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 175 | 34 | 3 | 61fbd8f685d3daad46449e4c0386a38886496566 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.17e-04 | 175 | 34 | 3 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 175 | 34 | 3 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 175 | 34 | 3 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 175 | 34 | 3 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.22e-04 | 176 | 34 | 3 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | facs-Trachea-3m-Hematologic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-04 | 177 | 34 | 3 | c9d235fc518b291ed98088a1206d14d6692bc7fd | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 177 | 34 | 3 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-04 | 177 | 34 | 3 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | severe-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.27e-04 | 177 | 34 | 3 | d1ad35ee3d2a84b1d01126d0a38464ab858c00d0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-04 | 177 | 34 | 3 | d7976eac7e27044f6a859cc0c3398d08576e8c01 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 177 | 34 | 3 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.33e-04 | 178 | 34 | 3 | c655b72ec22d45d2da69c2d8886a01831ce79558 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.33e-04 | 178 | 34 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 178 | 34 | 3 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 4.78e-05 | 10 | 31 | 2 | EFO_0008321 | |
| Disease | photoreceptor cell layer thickness measurement | 5.01e-04 | 148 | 31 | 3 | EFO_0803370 | |
| Disease | triacylglycerol 52:5 measurement | 6.22e-04 | 35 | 31 | 2 | EFO_0010417 | |
| Disease | Depression, Neurotic | 8.54e-04 | 41 | 31 | 2 | C0282126 | |
| Disease | Melancholia | 8.54e-04 | 41 | 31 | 2 | C0025193 | |
| Disease | Depressive Syndrome | 8.96e-04 | 42 | 31 | 2 | C0086133 | |
| Disease | age at onset, alcohol dependence | 8.96e-04 | 42 | 31 | 2 | EFO_0004847, MONDO_0007079 | |
| Disease | eosinophil percentage of leukocytes | 1.00e-03 | 746 | 31 | 5 | EFO_0007991 | |
| Disease | asthma | 1.03e-03 | 751 | 31 | 5 | MONDO_0004979 | |
| Disease | Endogenous depression | 1.07e-03 | 46 | 31 | 2 | C0011573 | |
| Disease | body composition measurement | 1.08e-03 | 193 | 31 | 3 | EFO_0005106 | |
| Disease | Hepatic fibrosis | 1.22e-03 | 49 | 31 | 2 | HP_0001395 | |
| Disease | Uveal Melanoma | 1.42e-03 | 53 | 31 | 2 | EFO_1000616 | |
| Disease | Thyroid preparation use measurement | 1.51e-03 | 217 | 31 | 3 | EFO_0009933 | |
| Disease | Alzheimer disease, educational attainment | 2.19e-03 | 247 | 31 | 3 | EFO_0011015, MONDO_0004975 | |
| Disease | joint damage measurement | 2.33e-03 | 68 | 31 | 2 | EFO_0005413 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LECENWLENQQGNQE | 156 | Q9HBT8 | |
| VLACDQAQCRWLNVQ | 491 | P22792 | |
| NSHCVDCETQNPNWA | 621 | Q9UPQ3 | |
| ALQPCQGQACQDRWF | 961 | Q6UY14 | |
| VNAQCWPEQESRLCN | 241 | O95388 | |
| SDWNPQNDLQAQARC | 1386 | Q9P2D1 | |
| LWVKQNNRCPLCQQD | 91 | Q9UBF6 | |
| NNRCPLCQQDWVVQR | 96 | Q9UBF6 | |
| GQNLARQWCNCAFLE | 131 | P62834 | |
| DCQCELNQAAGRWPA | 531 | Q9NPA2 | |
| PCWDYINNQCDELCN | 1471 | Q04721 | |
| NNCIPDHWRCDSQND | 3486 | Q9NZR2 | |
| NGRCININWRCDNDN | 986 | Q07954 | |
| NINWRCDNDNDCGDN | 991 | Q07954 | |
| ALDQNCQWEPRNQEC | 766 | O75882 | |
| VQNDQCQPNADDSRW | 206 | Q6UXG2 | |
| PVDTQACNQQLCVEW | 1596 | Q8N6G6 | |
| RIANNPWHCDCTLQQ | 141 | Q96PB8 | |
| EWQLQACEDQQCCPE | 121 | P27918 | |
| QLQLNPNIWVECNNC | 211 | P78509 | |
| PNIWVECNNCETGEQ | 216 | P78509 | |
| SLNLNCQWDQRQQEC | 726 | Q5VV63 | |
| CQWDQRQQECQALPA | 731 | Q5VV63 | |
| QDWNDPKSQLQQCCL | 1256 | Q9NRR4 | |
| TCQENRQWQCDQEPC | 126 | Q9GZM7 | |
| QLLQVGDNPWECDCN | 191 | Q8N967 | |
| VNSRCQAICDQWDNL | 486 | Q08043 | |
| AQHQDWRQCQPQVQA | 46 | Q9NYJ1 | |
| AAPCALENEDICQWN | 191 | Q8TBF5 | |
| QWVRCNPDSNSANCL | 36 | P10124 | |
| VCQDCLLRNWQDQPS | 366 | Q495X7 | |
| SQDILCDALQQWACN | 66 | Q9BSF0 | |
| DWECRNQFDRQQGNP | 121 | Q96NG8 | |
| NQIQYQCWDCQELFP | 136 | Q8TF50 | |
| PQCSTDGQWRQVQCN | 761 | P01266 | |
| AQQANLWCLSRCVQE | 1886 | P01266 | |
| SLEEWQCLDCAQQNL | 26 | A0A1W2PQL4 | |
| ELQNQCIKANERCWA | 1566 | Q8NEV4 | |
| RCEVGTNNWVQCNDA | 421 | P54296 |